Status:
COMPLETED
Woebot for Substance Use Disorders
Lead Sponsor:
Woebot Health
Collaborating Sponsors:
Stanford University
Conditions:
Substance Use Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Phase 1 of this study aims to develop a digitally-delivered substance use disorder program through the Woebot app-based platform (W-SUDs) and evaluate the effectiveness of, patient satisfaction with a...
Eligibility Criteria
Inclusion
- All genders
- 18-65 years
- Must have access to a smartphone and able to download the W-SUDs app
- Committed to engage with app and complete assessments
- Be willing to provide email address (to distribute incentives)
- Be literate in English (as W-SUDs conversational and video materials will be in English)
- Endorse a substance use concern according to the DAST-10 and/or AUDIT-C scale cutoffs for problematic use
Exclusion
- Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
- Suicide attempt or within the past year
- Drug or alcohol overdose within the past year
Key Trial Info
Start Date :
March 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04096001
Start Date
March 26 2020
End Date
August 31 2020
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Woebot Labs Inc
San Francisco, California, United States, 94107